Samie Modak, Shivani Shinde, Sohini Das

Stories by Samie Modak, Shivani Shinde, Sohini Das

Zomato's Rs 9,375-cr IPO to open on July 14

Zomato's Rs 9,375-cr IPO to open on July 14

Rediff.com   8 Jul 2021

Food delivery company Zomato's Rs 9,375-crore initial public offering (IPO) will open for subscription on July 14, said investment banking sources on Wednesday. The company initially was looking to raise Rs 7,500 crore through the offering. Investment banking sources said the issue size has been increased because of the robust demand from investors.

Nasper-backed PayU in talks to acquire BillDesk for up to $4 billion

Nasper-backed PayU in talks to acquire BillDesk for up to $4 billion

Rediff.com   7 Jul 2021

Nasper-backed fintech firm PayU has started talks to acquire domestic payment gateway major BillDesk, and the deal size could be in the range of $3-4 billion, sources in the know said. "BillDesk has been open to being acquired for some time now, but in the past the valuations that the company was seeking proved to be a hurdle," said a source. "Three years ago too, PayU had approached BillDesk for an acquisition, but things didn't go ahead due to high valuations. "BillDesk had asked for $2-billion value then," said the source.

Zomato mega IPO likely this month following Sebi nod

Zomato mega IPO likely this month following Sebi nod

Rediff.com   6 Jul 2021

The company, backed by China's Ant Group, is planning to issue fresh shares worth Rs 7,500 crore in the IPO. This will make this India's third-largest offering after Reliance Power and DLF.

Fear and myths injecting Covid vaccine hesitancy

Fear and myths injecting Covid vaccine hesitancy

Rediff.com   6 Jul 2021

A June 11 survey by cLocalCircles across 299 districts puts overall vaccine hesitancy levels at 18 per cent, with 11 per cent of the respondents saying they were not convinced if the currently available vaccines would protect them against the new strains; and 5 per cent said they do not plan to take the vaccine at all.

Why Thyrocare sold out to PharmEasy

Why Thyrocare sold out to PharmEasy

Rediff.com   5 Jul 2021

'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'

Gourmet meals on wheels, 5-stars' latest success mantra

Gourmet meals on wheels, 5-stars' latest success mantra

Rediff.com   4 Jul 2021

Since home-delivered meals from five-stars are cheaper by 15 to 20 per cent as compared to eating at the destination outside, food delivery has emerged as an important part of every restaurant's service portfolio.

Analysts expand stock coverage amid sharp market rally

Analysts expand stock coverage amid sharp market rally

Rediff.com   3 Jul 2021

Brokerages are expanding the universe of stocks they cover amid a boom in the market. Several stocks in the mid-cap universe are now tracked by more analysts than they were a year ago. For instance, SBI Cards and Payment Services is now tracked by 17 brokerages, compared to just four a year ago.

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com   2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

'Covid vaccines are working against new variants'

'Covid vaccines are working against new variants'

Rediff.com   2 Jul 2021

'The key purpose of vaccination is to prevent hospitalisation, severe disease, and death.' 'All vaccines work equally, although mild disease cannot be prevented.'

Serum applies for EU Covishield nod through AstraZeneca

Serum applies for EU Covishield nod through AstraZeneca

Rediff.com   30 Jun 2021

We have applied for marketing authorisation to the EMA through AstraZeneca. We will not sell the vaccine in the EU, said a company source.

Cyber Fraud Helpline: How it Works

Cyber Fraud Helpline: How it Works

Rediff.com   29 Jun 2021

Since its launch in April, helpline 155260 has been able to prevent more than Rs 18.5 million of defrauded money from reaching the hands of fraudsters.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com   28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

At current rate, all Indians will be vaccinated by Sept 2022

At current rate, all Indians will be vaccinated by Sept 2022

Rediff.com   28 Jun 2021

865 million Indian adults require vaccination.

Covid: What is Delta, Delta Plus & can vaccines fight it?

Covid: What is Delta, Delta Plus & can vaccines fight it?

Rediff.com   24 Jun 2021

While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.

NSDL statement prevents a $500-million sell-off in Adani group stock

NSDL statement prevents a $500-million sell-off in Adani group stock

Rediff.com   23 Jun 2021

The clarification by the National Securities Depository (NSDL) - which is tasked with monitoring foreign portfolio investor (FPI) investment in domestic stocks - that the accounts of top investors in Adani group stocks remain 'active' has helped prevent a $500-million selloff of shares. Analysts said a freeze of the FPI accounts, as reported by some media outlets, could have prompted global index providers to cut weighting of four Adani group companies from their global indices. Brian Freitas, an analyst at independent research provider Smartkarma, said if the FPI accounts were indeed frozen, FTSE and MSCI would have reduced weighting of Adani group companies at the next rebalance, since it would have meant that the large part of the free float was not tradeable.

As data hacks rise, firms turn to bug bounty hunters

As data hacks rise, firms turn to bug bounty hunters

Rediff.com   22 Jun 2021

Bug bounty hunters or independent ethical hackers are certified cybersecurity professionals or security researchers who crawl the web, scanning the systems for gaps through which hackers can sneak in and alert the companies, says Shivani Shinde.

Dilution norms for large IPOs tweaked

Dilution norms for large IPOs tweaked

Rediff.com   21 Jun 2021

Easier dilution norms for mega initial public offerings (IPOs) have come into effect. Companies with post-listing market capitalisation (m-cap) of more than Rs 1 trillion will not be required to dilute a minimum of 10 per cent. The move to relax dilution norms is seen as a precursor to Life Insurance Corporation's IPO. The central government has said companies with an m-cap exceeding Rs 1 trillion will have to dilute Rs 5,000 crore and at least 5 per cent of their m-cap. Experts said the earlier framework discouraged large companies from listing since they were forced to offload a large volume of shares during the time of their IPO.

Decoded: What went wrong with the six schemes of Franklin Templeton

Decoded: What went wrong with the six schemes of Franklin Templeton

Rediff.com   19 Jun 2021

The Securities and Exchange Board of India (Sebi) has directed Franklin Templeton MF to pay Rs 5 crore as penalty, return over Rs 450 crore collected as 22-month investment management and advisory fees, and imposed a two-year ban on launching new debt schemes for alleged irregularities in running six of its debt schemes that were shuttered last year.

Novavax set for India launch with Serum Institute as partner

Novavax set for India launch with Serum Institute as partner

Rediff.com   15 Jun 2021

The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

Rediff.com   14 Jun 2021

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini Das